Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
CXCR4 mutation
i
Other names:
CXCR4, CD184, D2S201E, fusin, HM89, HSY3RR, LESTR, NPY3R, NPYR, NPYY3R, Chemokine (C-X-C motif) receptor 4
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
7852
Related biomarkers:
Expression
Mutation
‹
›
Associations
(10)
News
Trials
Search handles
@AaronGoodman33
@Abdallah81MD
@SLentzsch
@docbraunstein
Search handles
@AaronGoodman33
@Abdallah81MD
@SLentzsch
@docbraunstein
Filter by
Latest
1year
Good teaching case from @BloodJournal Images in #Hematology that (1) not all M-spikes are myeloma, (2) not all lymphoplasmacytic lymphomas are IgM isotype, and (3) remember to request MYD88 and CXCR4 mutations in this setting. #mmsm https://t.co/OpVazjbeNA (@docbraunstein)
1 year ago
MYD88 (MYD88 Innate Immune Signal Transduction Adaptor) • CXCR4 (Chemokine (C-X-C motif) receptor 4)
|
CXCR4 mutation • MYD88 mutation + CXCR4 mutation
over2years
Congratulations David and @fdezdelarrea for the excellent study on MYD88 and CXCR4 mutations in IgM MGUS and smoldering WM! Challenge accepted, we will try to improve the sensitivity of #flowcytometry to detect Waldenström's clonal cells! #ASH21 #mmsm (@BrunoPaiva_UNAV)
over 2 years ago
MYD88 (MYD88 Innate Immune Signal Transduction Adaptor) • CXCR4 (Chemokine (C-X-C motif) receptor 4)
|
CXCR4 mutation • MYD88 mutation + CXCR4 mutation
over2years
Venetoclax in Previously Treated Waldenström Macroglobulinemia @JCO_ASCO 👉🏻 ORR84%👉🏻CXCR4 mutations did not affect treatment response or progression-free survival #mmsm | Journal of Clinical Oncology https://t.co/jDzNGbOCPS (@SLentzsch)
over 2 years ago
Clinical
|
CXCR4 (Chemokine (C-X-C motif) receptor 4)
|
CXCR4 mutation
|
Venclexta (venetoclax)
over2years
IgM Plasma Cell Myeloma: Clinicopathologic Features Including Evaluation for MYD88 and CXCR4 Mutations https://t.co/HnYycjhKQj #mmsm #medEd #medtwitter (@Abdallah81MD)
over 2 years ago
Clinical
|
MYD88 (MYD88 Innate Immune Signal Transduction Adaptor) • CXCR4 (Chemokine (C-X-C motif) receptor 4)
|
CXCR4 mutation • MYD88 mutation + CXCR4 mutation
over2years
Recently,[Dale. Blood. 2020] showed the CXCR4 inhibitor mavorixafor can increase circulating PMNs and decrease infections in WHIM patients. Interestingly, the same CXCR4 mutation in WHIM is seen in Waldenstrom macroglobulinemia and is associated with worse responses to ibrutinib (@AaronGoodman33)
over 2 years ago
Clinical
|
CXCR4 (Chemokine (C-X-C motif) receptor 4)
|
CXCR4 mutation
|
Imbruvica (ibrutinib) • mavorixafor (X4P-001)
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login